Public Profile
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
- Gerald S. Berenson Endowed Chair
- in Preventive Cardiology, Professor of Medicine
- Tulane University School of Medicine
- New Orleans, LA
close
Affiliations
Emory University, the Association of Black Cardiologists
Disclosures
Dr. Keith C. Ferdinand has indicated the following relevant financial relationships: he is a consultant/speaker for Pfizer Inc, AstraZeneca, Merck, Bristol-Myers Squibb, and Novartis Pharmaceuticals Corporation.
| Program Name | Last Air Date | Hosts/Guests |
|---|---|---|
| LDL-C Management Trends in ASCVD Patients | 04/29/2025 | |
| Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice | 09/04/2024 | |
| Exploring Strategies to Eliminate Disparities in Cardiovascular Care | 05/01/2025 | |
| Addressing Racial Disparities in Cardiovascular Care | 04/26/2025 | |
| Updated NLA Recommendations for African American Patients | 04/29/2025 | |
| Metabolic Syndrome in African Americans: Risk Adjustments & Treatments | 05/01/2025 |
